The Royal Pharmaceutical Society (RPS) is refreshing its Professional Standards for Homecare Services and will be shared for consultation in August to allow
comment and input on the updated content.
The final version is expected to be completed in the autumn.
The standards were originally published in 2013 and are a framework to support teams providing and commissioning homecare services. Homecare medicines services
deliver medication, and any necessary associated care, direct to the patient's home with their consent.
The standards help patients experience a consistent quality of homecare services, irrespective of provider, will protect them from avoidable incidents and help them
get the best outcomes from their medicines.
Jennifer Allen, The Chief Pharmaceutical Officer's Clinical Fellow leading the refresh at RPS said: "It has been 10 years since the first set of Homecare Standards
were published, so it is important that they are reviewed and brought up to date to reflect current service design, medicine pathways and delivery models to ensure
patients receive safe and effective medication supply and associated care."
The Royal Pharmaceutical Society (RPS) has updated the Professional Standards for Homecare Services to ensure high quality care for patients receiving
medicines and associated services in the comfort of their own homes.
Originally published in 2013, these standards provide a comprehensive framework to support teams involved in planning, commissioning, and delivering homecare
services.
The RPS said that these standards were updated to ensure that they align with the needs and expectations of recipients of homecare services, as well as
commissioners and providers.
Changes were made based on responses received through a consultation process, which was participated by representatives from the National Homecare Medicines
Committee, the Association of Pharmacy Technicians, the Pharmacy Forum of Northern Ireland, and the Royal College of Nursing.
LloydsPharmacy Clinical Homecare, a leading provider of home healthcare services in the UK, on Monday announced the appointment of Paul Adams as the
company's new Chief Executive Officer (CEO).
Before assuming his role at LPCH at the end of last year, Adams was leading transformation efforts at DD Group, formerly known as Dental Directory.
With a career spanning over two decades, Adams has held influential positions at Diageo, Smith+Nephew, and served as a CEO for various Private Equity companies.
He has also co-authored "The Little Black Book of Change."
Adams will lead the LPCH's mission to pioneer the delivery of specialist clinical treatment therapies to patients, thereby enhancing patient outcomes within
homecare and community settings while improving accessibility.
In the competitive landscape of healthcare, strategic alliances can be a game-changer. Dr. Dupe, a General Practitioner at Christchurch Clinics, and Baba, a
Pharmacist at Christchurch Pharmacy, married for 24-years cultivate their synergy through mental wellbeing walks.
Their recent 24 kilometres fundraising walk to support a local hospice - Farleigh Hospice, is one of such.
Having met Dupe first in 1994, first as interns at a teaching hospital, now married, the couple offer a comprehensive range of services, including pharmacy, private
clinics, homecare services as proprietors of Christchurch Health-centre in Braintree.
gp; pharmacist; mental wellbeing walks, healthcare
Dupe and Baba in their clinic
Dr. Dupe and Pharmacist Baba Akomolafe in their clinic, demonstrating their synergy and dedication to patient care.
United by faith, a love for healthcare, and a shared commitment to service the community, their 'Mental Wealth Management' as they call it comprises of daily
morning walks covering a distance of six kilometres.
European asset management group Aurelius has completed the acquisition of McKesson UK, marking the company's fifth completed transaction in a year.
McKesson UK is the parent company of a number of healthcare businesses including LloydsPharmacy, John Bell & Croyden and AAH Pharmaceuticals.
It comprises four divisions and holds a substantial market share across each vertical: retail, digital, homecare and wholesale. McKesson UK's success has been underpinned by its strong LloydsPharmacy brand, its customer base and its leading commercial footprint across wholesale pharmaceuticals.
Over recent years, the company has benefited from the introduction of additional services delivered across its more than 1,300 pharmacies, a growing digital offering and the ability to support the increasing trend of primary care being delivered to patients in their home.